Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome

Effects of early recombinant human growth hormone treatment in young Chinese children with Prader–Willi syndrome

Abstract Background Prader–Willi syndrome (PWS) is a rare and multisystemic genetic disorder that is characterized by severe hypotonia, hyperphagia, short stature, and global developmental delay. Although early recombinant human growth hormone (rhGH) treatment has been proven to rescue some symptoms...

Full description

Bibliographic Details
Main Authors: Ying Gao, Li-Li Yang, Yang-Li Dai, Zheng Shen, Qiong Zhou, Chao-Chun Zou
Format: Article
Language:English
Published: BMC 2023-02-01
Series:Orphanet Journal of Rare Diseases
Subjects:
Prader–Willi syndrome
Growth hormone
Body composition
Length
Height
Carbohydrate metabolism
Online Access:https://doi.org/10.1186/s13023-023-02615-7

Internet

https://doi.org/10.1186/s13023-023-02615-7

Similar Items